Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Roivant Sciences logo

Roivant Sciences

Recent Finacing

Equity

Recent Raise

$200M

Roivant Sciences is a biotech holding that creates and operates independent "Vant" subsidiaries to acquire, advance, and commercialize shelved clinical assets and develop platforms like VantAI and Datavant.

Founded 2014
New York, United States
501-1K
Publicly Traded
roivant.com

Highlights

Focus Areas

Biopharma
Biotechnology
Health Care
Pharmaceutical
Product Research

Recent Investors

SoftBank logo
Viking Global Investors logo
QVT logo
Dexcel Pharma logo
RTW Investments logo
SK logo
NovaQuest Capital Management logo

Financials

$7B

Valuation as of 11/13/2018

$1.5B

Total Raised

3

Funding rounds

7

Investors


Team

Upgrade to view the team

See the team members at Roivant Sciences.